Strategic Business Transactions and Financial Results Releases - Analyst Notes on BP, Cameron International, Under Armour, Dr Pepper Snapple Group and Skechers USA

NEW YORK, April 28, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding BP Plc (NYSE: BP), Cameron International Corporation (NYSE: CAM), Under Armour, Inc. (NYSE: UA), Dr Pepper Snapple Group, Inc. (NYSE: DPS) and Skechers USA Inc. (NYSE: SKX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1724-100free.

BP Plc Analyst Notes
On April 22, 2014, BP Plc (BP) announced that it has agreed to sell interests in four BP-operated oilfields on the North Slope of Alaska to Hilcorp, a privately-held independent oil and natural gas exploration and production company in US. According to the Company, the deal allows it to focus on maximizing production from Prudhoe Bay and advancing the Alaska LNG opportunity. The sale agreement includes all of BP's interests in the Endicott and Northstar oilfields and a 50% interest each in both Liberty and Milne Point fields. In addition, the sale also includes BP's interests in the oil and gas pipelines associated with these fields. Lamar McKay, BP Upstream Chief Executive, said, "This agreement will help build a more competitive and sustainable business for BP in Alaska. It will allow us to play to two of our great strengths, managing giant fields and gas value chains." The full analyst notes on BP are available to download free of charge at:

http://www.analystsreview.com/1724-BP-28Apr2014.pdf

Cameron International Corporation Analyst Notes
On April 24, 2014, Cameron International Corporation (Cameron) reported its Q1 2014 financial results. Cameron's revenues reached a record first quarter high of $2.4 billion, up 18.0% YoY, on account of gains in the Drilling and Production Systems Group. The Company reported GAAP earnings per diluted share from continuing operations of $0.54 for Q1 2014, compared to $0.59 for Q1 2013; while excluding charges, EPS for the reporting quarter came in at $0.75, compared to $0.69 in Q1 2013. Cameron revised its guidance and now anticipates its Q2 2014 earnings from continuing operations (excluding charges) to be in the range of $0.84 to $0.89 per diluted share, and in the range of $3.80 to $4.10 per diluted share for full-year 2014. The full analyst notes on Cameron International are available to download free of charge at:

http://www.analystsreview.com/1724-CAM-28Apr2014.pdf

Under Armour, Inc. Analyst Notes
On April 24, 2014, Under Armour Inc. (Under Armour) announced its Q1 2014 financial results. The Company posted net revenues of $641.6 million, which reflected a significant growth of 36.0% YoY. Apparel net revenues, which contributed to nearly 72% of its Q1 2014 sales, was up 32.9% YoY to $459.2 million. Also, footwear net revenues, which contributed to nearly 18% of its Q1 2014 sales, saw a massive growth of 41.2% YoY to $114.0 million. The Company reported diluted EPS of $0.06 for the quarter, beating Zacks analysts' estimates and Q1 2013 reported EPS, both of $0.04. For full year 2014, the Company anticipates net revenues in the range of $2.88 billion to $2.91 billion, and operating income in the range of $331 million to $334 million. The full analyst notes on Under Armour are available to download free of charge at:

http://www.analystsreview.com/1724-UA-28Apr2014.pdf

Dr Pepper Snapple Group, Inc. Analyst Notes
On April 23, 2014, stock of Dr Pepper Snapple Group, Inc. (Dr Pepper) gained 4.0% to end the trading session at $54.48. Earlier in the day, the Company had released its Q1 2014 earnings report. Dr Pepper's quarterly EPS of $0.78 came in much higher as compared to $0.51 reported in Q1 2013, and also beat analysts' estimates by $0.19, according to street.com. The Company's net sales grew 1.3% YoY to $1,398.0 million, while income from operations increased massively by 32.0% YoY to $260 million during the quarter. For full year 2014, Dr Pepper forecasts net sales to be flat to up 1% and core EPS to be in the range of $3.38 to $3.46 The full analyst notes on Dr Pepper Snapple Group are available to download free of charge at:

http://www.analystsreview.com/1724-DPS-28Apr2014.pdf

Skechers USA Inc. Analyst Notes
On April 22, 2014, SKECHERS USA, Inc. (Skechers USA) reported its financial results for Q1 2014. Quarterly net sales came in at $546.5 million compared to $451.6 million in Q1 2013. According to David Weinberg, Chief Operating Officer and CFO, the sales results were attributable to double-digit increases in the Company's domestic and international wholesale business, as well as increases in its worldwide company-owned retail business, which achieved a 5.6% comparable quarter net sales increase. Furthermore, the Company registered a substantial growth in earnings from $6.7 million or $0.13 per diluted share in Q1 2013 to $30.7 million or $0.61 per diluted share in Q1 2014. On the day following the release, April 23, 2014, the stock opened the session at 41.37, up 12.2% from previous day's closing of $36.87. The full analyst notes on Skechers USA are available to download free of charge at:

http://www.analystsreview.com/1724-SKX-28Apr2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review